CASI Pharmaceuticals, Inc. (CASIF)
0.11
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
CASI Pharmaceuticals Net Income (Quarterly) : -13.04M for Dec. 31, 2025
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -13.04M |
| September 30, 2025 | -10.88M |
| June 30, 2025 | -13.38M |
| March 31, 2025 | -10.75M |
| December 31, 2024 | -14.37M |
| September 30, 2024 | -8.395M |
| June 30, 2024 | -6.965M |
| March 31, 2024 | -9.528M |
| December 31, 2023 | -5.343M |
| September 30, 2023 | -4.466M |
| June 30, 2023 | -10.07M |
| March 31, 2023 | -5.831M |
| December 31, 2022 | -19.34M |
| September 30, 2022 | -5.023M |
| June 30, 2022 | -7.493M |
| March 31, 2022 | -8.40M |
| December 31, 2021 | -5.395M |
| September 30, 2021 | -10.02M |
| June 30, 2021 | -6.744M |
| March 31, 2021 | -13.68M |
| December 31, 2020 | -14.02M |
| September 30, 2020 | -16.76M |
| June 30, 2020 | -8.498M |
| March 31, 2020 | -8.233M |
| December 31, 2019 | -12.28M |
| Date | Value |
|---|---|
| September 30, 2019 | -9.669M |
| June 30, 2019 | -15.25M |
| March 31, 2019 | -8.16M |
| December 31, 2018 | -9.265M |
| September 30, 2018 | -8.756M |
| June 30, 2018 | -5.860M |
| March 31, 2018 | -3.591M |
| December 31, 2017 | -5.048M |
| September 30, 2017 | -1.614M |
| June 30, 2017 | -2.409M |
| March 31, 2017 | -1.700M |
| December 31, 2016 | -2.674M |
| September 30, 2016 | -1.694M |
| June 30, 2016 | -3.292M |
| March 31, 2016 | -1.794M |
| December 31, 2015 | -1.703M |
| September 30, 2015 | -1.605M |
| June 30, 2015 | -2.096M |
| March 31, 2015 | -1.803M |
| December 31, 2014 | -1.597M |
| September 30, 2014 | -21.54M |
| June 30, 2014 | -1.616M |
| March 31, 2014 | -1.451M |
| December 31, 2013 | -1.308M |
| September 30, 2013 | -1.442M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.222M |
| Total Expenses (Quarterly) | 20.26M |
| EPS Diluted (Quarterly) | -0.6345 |
| Gross Profit Margin (Quarterly) | 51.14% |
| Profit Margin (Quarterly) | -180.6% |